Clinical study on the use of low-dose cytosine arabinoside (Ara-C) in the treatment of myelodysplastic syndromes and acute myelogenous leukemia.

Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute myelogenous leukemia.

CAZZOLA, MARIO;RICCARDI, ALBERTO
1987-01-01

Abstract

Clinical study on the use of low-dose cytosine arabinoside (Ara-C) in the treatment of myelodysplastic syndromes and acute myelogenous leukemia.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/452664
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact